跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOLPAZA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NOLPAZA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG
Approved
STANDARD
NOLPAZA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 8, 2023
Approval ID
a0c28d00f8610d80
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
a0c28d00f8610d80
Drug Cima Aemps Name
NOLPAZA 20 MG COMPRIMIDOS GASTRORRESISTENTES EFG
Register Number
14134IP
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-11-08
Dosage Form
COMPRIMIDO GASTRORRESISTENTE
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Active Ingredients
PANTOPRAZOL SODICO SESQUIHIDRATO
22,55 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 8, 2023
Approval ID
a0c28d00f8610d80
Type
Standard
Back to CIMA-AEMPS Approvals
